Basic data | |
sex ratio (M/F) | 17/13 |
gestational age of birth (weeks)a | 28.6 [24.3–41.1] |
birth weight (g)a | 930 [515–3770] |
intra-uterine growth retardation, no (%) | 10 (33.3%) |
antenatal corticosteroids, no (%) | 26 (86.7%) |
caesarean, no (%) | 25 (83.3%) |
Apgar score (5 min)a | 9 [1–10] |
surgery before sepsis, no (%) | 2 (6.7%) |
E. cloacae in the vaginal sample of the mother, no (%) | 1 (3.3%) |
Sepsis data | |
colonization with E. cloacae before sepsis, no (%) | 4 (13.3%) |
age at the onset of sepsis (days)a | 7 [0–50] |
fever, no (%) | 11 (36.7%) |
respiratory signs, no (%) | 21 (70%) |
hemodynamic signs, no (%) | 27 (90%) |
gastrointestinal signs, no (%) | 15 (50%) |
hyperglycaemia, no (%) | 4 (13.3%) |
central venous line at onset, no (%) | 23 (76.7%) |
CSF positive for E. cloacae, no (%) | 2/18b (11%) |
Evolution | |
length of staya,d | 47 [10–185] |
necrotizing enterocolitis, no (%) | 4 (13.3%) |
death / death caused by sepsis, no (%) | 12 (40%)/ 10 (33.3%) |
delay between onset of sepsis and death (days)a | 3 [0–26] |
Management | |
central venous line removal, no (%) | 7/23c (30.4%) |
Antibiotics | |
Carbapenem, no (%) | 24 (80%) |
Cephalosporins, no (%) | 24 (80%) |
Aminoglycosides, no (%) | 30 (100%) |
Ciprofloxacin, no (%) | 5 (16.7%) |
Piperacillin, no (%) | 1 (3.3%) |
duration of antibiotic (days)a,d | 15 [10–34] |